KAKingsley Chukwuebuka Agu

Kingsley Chukwuebuka Agu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kingsley Chukwuebuka Agu has a total of 228 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Global Core Patient-Reported Outcome Set for Menopause: Development and Validation of the cPRO-MARiE Framework Across Thirteen Countries (MARIE WP2a)

    by Gayathri Delanerolle, Ieera Madan-Aggarwal, Vindya Pathiraja, George Uchenna Eleje, Teck Hock Toh, Nirmala Rathnayake, Fred Tweneboah-Koduah, Nana Afful-Minta, Tharanga Mudalige, Jie Sun, et al.

    Background: Menopause affects more than one billion individuals worldwide, yet outcome measurement in research remains narrow, inconsistent, and largely focused on vasomotor and genitourinary symptoms. Existing frameworks do not adequately capture the broader functional and psychosocial impacts reported by patients. We aimed to develop and validate a global Core Patient-Reported Outcome Set for Menopause (cPRO-MARiE) using prospective mixed-methods data from thirteen countries. Methods: We analysed quantitative data from 5,228 participants and qualitative interviews from 302 individuals across thirteen countries spanning diverse socio-cultural and health-system contexts. Validated instruments assessed symptom severity, psychological wellbeing, cognitive function, sleep disturbance, pain and somatic symptoms, and functional outcomes. Qualitative data underwent reflexive thematic analysis guided by the Delanerolle–Phiri framework. A COMET-aligned process integrating quantitative severity patterns, qualitative thematic convergence, cross-country reproducibility, psychometric validation and equity considerations was applied to derive the core outcome set. Findings: Seven domains were consistently identified across all settings: sleep disturbance; psychological wellbeing; cognitive function; pain and somatic symptoms; vasomotor symptoms; genitourinary and sexual health; and social, relational and occupational functioning. These domains demonstrated conceptual stability, cross-country reproducibility and psychometric coherence and were strongly linked to functional impact. The resulting cPRO-MARiE specifies mandatory Tier 1 patient-reported outcomes within each domain, with Tier 2 outcomes retained for context-specific and equity-focused research. Interpretation: cPRO-MARiE is the first empirically derived, globally validated core outcome set for menopause. By capturing symptom domains and functional impacts prioritised by patients across diverse settings, it provides a robust and clinically meaningful framework for outcome measurement in research, routine care, and health-system evaluation.

  • Open Access

    Hidden in Plain Sight; Menopause as a Global Determinant of Burnout and Workforce Disruption: A Mixed-Methods Analysis from Thirteen Countries in MARIE WP2a

    by Gayathri Delanerolle, Ieera Madan-Aggarwal, Vindya Pathiraja, George Uchenna Eleje, Teck Hock Toh, Nirmala Rathnayake, Fred Tweneboah-Koduah, Nana Afful-Minta, Tharanga Mudalige, Jie Sun, et al.

    Background: Menopause is a universal life-course transition that coincides with midlife employment for a growing proportion of the global female workforce. Despite increasing recognition, robust cross-country evidence linking menopausal symptoms to burnout and workforce wellbeing remains limited, particularly outside high-income settings. Methods: This mixed-methods analysis draws on MARIE WP2a, a multi-country cross-sectional cohort of 5,133 participants aged 40–65 years across 13 countries (Brazil, Ghana, India, Sri Lanka, Malaysia, Nigeria, Nepal, Oman, Pakistan, Rwanda, Singapore, Tanzania, and the UK). Quantitative data assessed burnout using the Burnout Assessment Tool (BAT-12) and its subscales (exhaustion, mental distance, cognitive impairment, emotional impairment). Linear mixed-effects models examined associations with employment characteristics, health factors, and menopausal treatments. Qualitative interviews were synthesised with a topics guide using cross-country thematic analysis to contextualise workforce impacts. Results: Overall burnout burden was moderate (mean BAT-12 2.41, SD 0.84), with exhaustion and cognitive impairment most pronounced. Participants early in their current specialty (1–5 years) consistently demonstrated higher burnout and subscale scores than those with ≥21 years’ experience. Disability and long-term conditions were associated with significantly higher burnout across domains. Marked cross-country heterogeneity was observed, reflecting differences in labour structures and social protection. Qualitative findings revealed convergent mechanisms across countries: symptom-driven capacity loss, amplification by inflexible work structures, stigma and non-disclosure, reliance on informal support, policy absence, and financial precarity. Conclusions: Menopause substantially shapes workforce wellbeing across diverse economic and cultural contexts. Symptoms interact with job demands, stigma, and inequitable access to care to drive presenteeism, reduced productivity, and constrained occupational choice. Menopause-informed workplace policies, manager training, low-cost job adjustments, and equitable access to evidence-based care are urgently required to protect women’s health, workforce participation, and productivity in ageing economies.

  • Open Access

    Contextualising Menopause in Nigeria: A Qualitative Analysis from the MARiE Project

    by George Uchenna Eleje, Isaiah Chukwuebuka Umeoranefo, Eziamaka Pauline Ezenkwele, Chukwuemeka Chijindu Njoku, Ayyuba Rabiu, Chijioke Chimbo, Chinedu Onwuka Ndukwe, Divinefavour Echezona Malachy, Lydia Ijeoma Eleje, Emmanuel Chukwubuikem Egwuatu, et al.

    Objective This study is to provide evidence from Nigeria on women’s lived experiences of menopause is sparse, necessitating qualitative inquiry to inform contextually appropriate interventions.DesignProspective cross - sectional study SettingUrban and rural regions of NigeriaPopulation or SampleMidlife womenMethods As part of the MARIE project, semi-structured interviews were conducted with midlife women across urban and rural regions of Nigeria. Participants were purposively sampled to capture diverse socioeconomic backgrounds and menopausal stages. Data were analysed using thematic content analysis, with coding informed by health inequality and gender frameworks, and findings were triangulated by multiple researchers to enhance validity.Results Analysis revealed three overarching themes: (1) structural inequalities in healthcare, including delayed recognition of symptoms, inadequate clinician knowledge, and limited access to hormone replacement therapy; (2) sociocultural and gendered barriers, such as stigma, misperceptions of menopause as a “natural end” requiring no care, and silencing within families; and (3) coping and resilience strategies, encompassing reliance on peer networks, faith-based approaches, and lifestyle adaptations in the absence of formal support. Urban participants reported marginally better access to information and services, while rural women described significant neglect, often relying on informal care.Main Outcome MeasuresThemes emerged from the qualitative interviewsConclusionsThis study highlights profound inequalities shaping menopausal experiences in Nigeria, reflecting gaps in healthcare training, policy attention, and community awareness. The findings emphasise the need for integrated, culturally sensitive strategies, including the incorporation of menopause into primary care, universal access to safe affordable treatments, and targeted public health education.


  • Open Access

    Prevalence of Multidrug-Resistant Escherichia coli O157:H7 from Live Bird Markets in Lagos, Nigeria

    by Sandra Okoye, Chidimma Chukwunwejim, Nzube Ekpunobi, Oluwabunmi Ajasa, Israel Ojuade, Nwasoluchukwu Obidi, Kingsley Agu

    Escherichia coli (E. coli), a gram-negative bacterium, is a major concern for human and animal health. While most E. coli strains are commensal, some can become dangerous pathogens causing intestinal and systemic illnesses. Poultry meat is a potential source of infection; as resistant E. coli can be transmitted to humans through the food chain. This study aimed to determine the prevalence and antibiotic resistance patterns of E. coli O157:H7 in poultry feces from a live bird market in Lagos, Nigeria.Samples were enriched in TSB (9 mL) at 37 °C for 18–24 h, plated onto EMB and SMAC agar, and presumptive E. coli O157 isolates (non-sorbitol fermenters) were confirmed by latex agglutination, following the manufacturer’s instructions. Antimicrobial susceptibility testing was performed on confirmed E. coli O157 isolates using the Kirby-Bauer disc diffusion method.A total of 180 poultry fecal samples were analyzed. Out of these, 105 (58.33%) were identified as Escherichia coli isolates. The isolation process further revealed that 74 (41.11%) of the isolates were non-sorbitol fermenters, and 26 (14.44%) were confirmed as Escherichia coli O157:H7 using the latex agglutination test. The isolates showed high resistance to most of the tested antibiotics.The findings indicate a high prevalence and a high level of multidrug resistance in E. coli O157:H7 from indigenous chickens in Lagos' live bird markets. The presence of these pathogenic and resistant organisms poses a significant public health risk to individuals with direct contact with the birds and to consumers in Nigeria.

  • Open Access

    Gut Microbiome Dynamics and Their Emerging Role in Breast and Colorectal Cancer: Implications for Diagnosis and Therapy

    by Chukwunwejim C. R., Nzube F. Ekpunobi, Eddison Igho Oghonyon, Nwasoluchukwu Obidi, Kingsley C. Agu

    The gut microbiome, a complex community of microorganisms residing in the gastrointestinal tract, is increasingly recognized as a critical player in cancer pathophysiology. Its influence extends beyond local gastrointestinal disorders to systemic diseases, including breast and colorectal cancers. This review examines current evidence on the interplay between gut microbial dysbiosis and the development, progression, and treatment response in both malignancies. In colorectal cancer (CRC), pathogenic bacteria such as Fusobacterium nucleatum, Escherichia coli, and Bacteroides fragilis have been implicated in tumor initiation and progression through mechanisms involving chronic inflammation, DNA damage, and immune modulation. Meanwhile, in breast cancer, the gut microbiome may contribute indirectly via regulation of estrogen metabolism, immune signaling, and systemic inflammation. Furthermore, the gut microbiota is increasingly being explored as a source of non-invasive biomarkers for early detection and disease monitoring, as well as a modifiable factor that could enhance therapeutic efficacy. Interventions such as probiotics, prebiotics, dietary modulation, and fecal microbiota transplantation (FMT) hold promise in reprogramming the microbiome to support antitumor responses and reduce treatment-related toxicity. Despite the growing body of research, translating these findings into clinical application requires deeper mechanistic understanding and standardized methodologies. This review emphasizes the need for longitudinal and multi-omics studies to unravel causal relationships and identify therapeutic targets. Understanding gut microbiome dynamics offers exciting opportunities for developing microbiota-informed strategies for cancer prevention, diagnosis, and therapy—particularly in breast and colorectal cancers.

  • Open Access

    Antimicrobial Resistance in Pediatric UTIs: Molecular Profiles, Clinical Burden, and Public Health Implications of ESBL-Producing Uropathogens

    by Nzube Ekpunobi, Malachy Ugwu, Kingsley Agu, Chidimma Chukwunwejim, Eddison Oghonyon, Temitope Ogunmola, Oluwabunmi Ajasa, Sandra Okoye, Nwasoluchukwu Obidi

    Urinary tract infections (UTIs) remain a common and serious health challenge among pediatric populations, particularly in low- and middle-income countries. The emergence of extended-spectrum beta-lactamase (ESBL)-producing uropathogens significantly complicates treatment, increases the risk of complications, and burdens already fragile healthcare systems. This review provides a comprehensive analysis of the epidemiology, molecular mechanisms, clinical impact, and treatment challenges associated with ESBL-producing Enterobacteriaceae in pediatric UTIs, with a focused lens on Nigeria and the broader Sub-Saharan African region. We examine the predominance of Escherichia coli and Klebsiella pneumoniae as key ESBL producers, highlight the molecular dominance of CTX-M-15 and co-existing resistance determinants, and discuss the role of clonal expansion and horizontal gene transfer in the spread of resistance. Regional surveillance data reveal alarming ESBL prevalence rates of 40–75%, with multidrug resistance further narrowing treatment options. The implications are profound—ranging from delayed treatment and increased hospitalization to long-term renal complications in children. Despite the availability of phenotypic and molecular diagnostics, challenges persist due to limited access, infrastructural gaps, and under-resourced healthcare systems. This review underscores the urgent need for improved antimicrobial stewardship, investment in rapid diagnostics, and the establishment of pediatric-specific treatment guidelines. Addressing the burden of ESBL-producing uropathogens in Nigerian children is critical for safeguarding individual patient outcomes and mitigating the regional and global spread of antimicrobial resistance.


  • Open Access

    Menstrual Health and Endometriosis: An Urgent Issue in Africa

    by Chisom Nri-Ezedi, Bernard Mbwele, David Ikwuka, Peter Phiri, Sohier Elneil, Gayathri Delanerolle, Om Kurmi, George Uchenna Eleje, Lydia Ijeoma Eleje, Sunday Onyemaechi Oriji, et al.

    Menstrual health in Africa is often neglected due to stigma, poor access to products, sanitation, and education, disproportionately affecting marginalized groups. Common menstrual disorders like dysmenorrhoea and menorrhagia are frequently undiagnosed. Endometriosis, affecting 5–10% of reproductive-age women, remains underdiagnosed due to healthcare gaps and limited research. Menstrual health inequities are deeply rooted in sociocultural barriers, misinformation, and restricted access to care. The absence of comprehensive menstrual health education in schools and communities fosters stigma and leaves many individuals unprepared to manage their health. In rural and resource-constrained settings, poor sanitation and limited healthcare exacerbate these issues, contributing to school and workplace absenteeism. The economic burden of menstrual health conditions, including endometriosis, further strains affected individuals and their families due to high healthcare costs and lost income. Transgender and non-binary individuals face additional challenges, including systemic healthcare barriers, stigma, and inadequate clinical recognition of their menstrual health needs. A lack of research on their experiences leads to significant gaps in care, further marginalising an already vulnerable population. To address these challenges, a multifaceted approach is required. Improved clinical guidelines, provider training, and culturally sensitive policies are necessary to enhance diagnosis and treatment. Grassroots awareness campaigns can dismantle stigma and improve access to menstrual health education. Enhancing healthcare infrastructure, integrating menstrual health into primary care, and expanding research on menstrual disorders and endometriosis are vital for achieving equity in Africa.Addressing menstrual health inequities and endometriosis in Africa requires urgent, integrated interventions across health, education, and social systems. By prioritising early detection, accessible care, and education, we can mitigate the long-term impacts of these conditions and improve the quality of life for all affected individuals. Sustainable solutions demand collaboration among policymakers, healthcare providers, educators, researchers, and communities to foster inclusive, evidence-based approaches to menstrual health.


  • Open Access

    Prevalence of Pathogenic Bacterial and Antimicrobial Resistance on Eggshells from Markets in Lagos, Nigeria: Implications for Public Health and Food Safety

    by Nzube Ekpunobi, Nwasoluchukwu Obidi, Chiamaka Chidozie, Kingsley Agu

    This study investigates the prevalence of pathogenic bacteria on eggshells from table eggs sold in Lagos markets, a major concern given eggs' role as a staple in the Nigerian diet. Fifty-one eggs were sampled from three poultry farms and three supermarkets, with bacterial isolation and identification conducted via microbiological assays and biochemical testing. The findings revealed that all eggshell samples (100%) were contaminated with various bacterial genera, including Staphylococcus aureus, Escherichia coli, Bacillus cereus, and Salmonella typhimurium. Staphylococcus aureus was the most frequently isolated organism, indicating a high potential risk for foodborne illness. Antimicrobial susceptibility tests indicated widespread resistance to first-line antibiotics, such as erythromycin and penicillin, with isolates only susceptible to gentamicin and ciprofloxacin. This study underscores the public health threat posed by contaminated eggs in Lagos and highlights the need for improved biosecurity measures, enhanced market hygiene, public awareness campaigns, and systematic surveillance under the One Health framework to combat bacterial contamination and antimicrobial resistance.

  • Open Access

    Prevalence of Esbl Genes in Klebsiella pneumoniae from Individuals with Community Acquired Urinary Tract Infections in Lagos State, Nigeria

    by Nzube Favour Ekpunobi, Uchechukwu Glory Mgbedo, Lydia Chidinma Okoye, Kingsley Chukwuebuka Agu

    Several efforts have been made to estimate the prevalence of different types of antibiotic resistance in different regions of Nigeria. The study investigated the prevalence of Klebsiella pneumoniae encoding genes for CTX-M, TEM, and SHV-1 extended-spectrum beta-lactamases (ESBL) enzymes isolated from urine samples of non-hospitalized patients with suspected UTI in Lagos State, Nigeria. A 4-month retrospective study, spanning from May 2023 to August 2023, was conducted. K. pneumoniae was isolated from urine samples using standard microbiological methods. The modified Kirby-Bauer disc diffusion method was used to test for antibiotic susceptibility, and Clinical and Laboratory Standard Institute (CLSI) guidelines were followed for interpretation. The double-disk synergy method was used to confirm the phenotypic identity of ESBL producers, and the results were interpreted in accordance with CLSI guidelines. The phenotypic method was utilized for ESBL screening, employing the standard disk diffusion method. The CTX-M ESBL gene, TEM gene, and SHV gene were found using multiplex PCR. Results revealed that 41 K. pneumoniae isolates were resistant to third-generation Cephalosporins; the isolates showed resistance to ceftazidime in 100% of cases and ceftriaxone in 80.49% of cases respectively. It was determined that 8 (19.51%) of the isolates produced ESBL. Among Klebsiella isolates, the frequencies of the SHV, TEM, and CTX-M genes were 31 (75.61%), 4 (9.76%), and 10 (24.39%), in that order. Four isolates (9.67%) had the SHV, TEM, and CTX-M genes, while eight (19.51%) of the isolates possessed both the SHV and CTX-M genes. This investigation demonstrates high frequency, wide range of patterns and coexistence of ESBL genes in K. pneumoniae isolates from outpatient UTI patients. Although several phenotypic tests have been used for ESBL detection, testing directly for the presence of ESBL genes is always more accurate. The majority of the isolates of Klebsiella pneumoniae ESBL producers had the SHV gene identified.